National Hospital for Tropical Diseases, Hanoi, Vietnam Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02334670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

National hospital for tropical diseases | National Hospital for Tropical Diseases, Hanoi, Vietnam

Active Ingredients

Drugs in Phase 2 Trials (3)

chloroquine (1 trial)

COVID-19 convalescent plasma (2 trials)

TD0069 (1 trial)

Drugs in Other Trials (1)

fluconazole (diflucan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4